Interesting

Study shows how daylight can boost the immune system’s ability to fight infections

A breakthrough study, led by scientists at Waipapa Taumata Rau, University of Auckland, has uncovered how daylight can boost the immune system's ability to fight infections.

The team focused on the most abundant immune cells in our bodies, called 'neutrophils', which are a type of white blood cell. These cells move quickly to the site of an infection and kill invading bacteria.

The researchers used zebrafish, a small freshwater fish, as a model organism, because its genetic make-up is similar to ours and they can be bred to have transparent bodies, making it easy to observe biological processes in real time.

"In earlier studies, we had observed that immune responses peaked in the morning, during the fish's early active phase," says lead researcher Associate Professor Christopher Hall, from the Department of Molecular Medicine and Pathology.

"We think this represents an evolutionary response such that during daylight hours the host is more active so more likely to encounter bacterial infections," says Hall.

However, the scientists wanted to find out how the immune response was being synchronised with daylight.

With this new study, published in Science Immunology, and led by two doctoral researchers, neutrophils were found to possess a circadian clock that alerted them to daytime, and boosted their ability to kill bacteria.

Most of our cells have circadian clocks to tell them what time of day it is in the outside world, in order to regulate the body's activities. Light has the biggest influence on resetting these circadian clocks.

Given that neutrophils are the first immune cells to be recruited to sites of inflammation, our discovery has very broad implications for therapeutic benefit in many inflammatory diseases.

This finding paves the way for development of drugs that target the circadian clock in neutrophils to boost their ability to fight infections."

Christopher Hall, Associate Professor, Department of Molecular Medicine and Pathology, University of Auckland

The research was funded through the Royal Society of NZ's Marsden Fund.

Current research is now focussed on understanding the specific mechanisms by which light influences the neutrophil circadian clock.

Source:

University of Auckland

Journal reference:

Du, L. Y., et al. (2025). A light-regulated circadian timer optimizes neutrophil bactericidal activity to boost daytime immunity. Science Immunology. doi.org/10.1126/sciimmunol.adn3080.


Source: http://www.news-medical.net/news/20250523/Study-shows-how-daylight-can-boost-the-immune-systems-ability-to-fight-infections.aspx

Inline Feedbacks
View all comments
guest

Wayne State research team tracks effects of bullying from high school to college

With funding from the Spencer Foundation, a private foundation focused on funding education studies, a Wayne State University...

Molecular Devices launches automated QPix FLEX Microbial Colony Picking System

Molecular Devices, LLC., a leading high-performance life science solutions provider, today launched the QPix® FLEX™ Microbial Colony Picking System....

NIH scientists pioneer new retinal grafting technique for dry age-related macular degeneration

National Institutes of Health (NIH) scientists have developed a new surgical technique for implanting multiple tissue grafts in...

Genetic discovery sheds light on infection-triggered neuropathy

Neuropathy, a disorder in which damage to nerves can impair sensation and movement, has many causes, including infection....

Study reveals continuing and worrying trend in excess US deaths

There were over 1.5 million "missing Americans" in 2022 and 2023, deaths that would have been averted if...

Study: Millions still lack access to basic eye care worldwide

Millions of people across the world still lack access to basic eye care such as glasses according to...

Chile joins Alliance for Primary Health Care in the Americas to strengthen primary healthcare

The Ministry of Health of Chile joined the Alliance for Primary Health Care in the Americas, a joint...

Ancient DNA sheds light on evolution of relapsing fever bacteria

Researchers at the Francis Crick Institute and UCL have analyzed ancient DNA from Borrelia recurrentis, a type of...

Machine learning tool identifies metabolic clues in colorectal cancer

Scientists aiming to advance cancer diagnostics have developed a machine learning tool that is able to identify metabolism-related...

Wastewater monitoring offers new tool for cervical cancer prevention

Scientists in Uruguay have found genotypes of the Human Papillomavirus (HPV) linked to cervical cancer in urban wastewater, saying it...

Endurance training leads to significant drops in vascular resistance and diastolic blood pressure

A new Finnish study shows that months of marathon training can lower peripheral blood pressure and vascular resistance,...

Public views vary widely about neurotechnologies for brain-based conditions

Q: How would you summarize your study for a lay audience?  Given the rise in brain-based conditions and...

New test can measure performance for lower-limb amputees using bone-anchored prostheses

A test developed at the University of Colorado Anschutz Medical Campus that measures both prosthetic donning time and...

ESMO releases updated scale to measure clinical benefit of cancer treatments

The European Society for Medical Oncology (ESMO) is pleased to announce the publication of the latest version of...

Study finds sharp rise in HIV prevention medication use among American youth

Eight times more American young adults now take medication to protect them from HIV than a decade ago,...

Guideline-directed medical therapy boosts survival in the oldest heart attack patients

Researchers have found that prescribing guideline-directed medical treatment (GDMT), regardless of the number of medications, can improve survival...

No early sex differences found in autism traits among toddlers

Males are more than four times more likely to receive an autism diagnosis than females. But a new...

Experimental ALS drug shows unprecedented recovery in some patients

When Columbia neurologist and scientist Neil Shneider speaks to his ALS patients who volunteer for experimental therapies, he's...

Living in disadvantaged neighborhoods linked to earlier menopause

A new study led by the Harvard Pilgrim Health Care Institute highlights the significant impact of living in...

Detecting balance impairments early could prevent life-threatening falls

As we get older, our bodies stop performing as they once did. We aren't as strong as we...